US · Healthcare · Biotechnology
EPS came in at -0.02 against a street estimate of -0.01 — a miss of 100.0%.
Analysts rate Geron Corporation a buy (6 buy, 3 hold, 0 sell out of 9) with an average price target of $4.25.
| Fund | Stake |
|---|---|
| RA Capital Management, LLC | 9.93% |
| BlackRock Inc | 7.37% |
| Soleus Capital Management, L.P. | 6.66% |
| State Street Corp | 4.75% |
| Vanguard Capital Management, LLC | 4.15% |
| Citadel Advisors Llc | 3.36% |
| Point72 Asset Management, L.P. | 3.18% |
| ClearBridge Advisors, LLC | 3.05% |
| Document | Date |
|---|---|
| Results announced · Q3 2026 GERON CORPORATION Q2 2026 FINANCIAL RESULTS SUMMARY HEADLINE NUMBERS • Q2 2026 RYTELO net product revenue: $57.5 million (11% increase vs Q1 2026) • | 2026-08-06 |
| Quarterly report · Q2 2026 GERON CORPORATION – FORM 10-Q SUMMARY Quarter Ended June 30, 2026 --- HEADLINE NUMBERS • Cash and marketable securities combined: $326.9 million (J | 2026-08-05 |
| Board / officer change · Q2 2026 GERON CORPORATION – 8-K SUMMARY HEADLINE NUMBERS • Annual shareholder meeting held May 20, 2026 (virtual format) • 4,500,000 new shares authorized u | 2026-05-27 |
| Quarterly report · Q1 2026 GERON CORPORATION – Q1 2026 SUMMARY HEADLINE NUMBERS • Product Revenue (Q1 2026): $51.8 million total revenues (product: $51.8M, royalties: $66K), u | 2026-05-06 |
| Proxy statement · Q2 2026 GERON CORPORATION PROXY STATEMENT SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Elect three directors to Class III Board positions (serving | 2026-04-07 |
| Board / officer change · Q1 2026 GERON CORPORATION - 8-K SUMMARY BUSINESS & SEGMENT HIGHLIGHTS • Geron Corporation (ticker: GERN, Nasdaq) elected two new Class III directors to its | 2026-03-26 |
| Annual report FY2025 GERON CORPORATION FORM 10-K SUMMARY HEADLINE NUMBERS • Market value of non-affiliate shares: approximately $860,500,000 (as of June 30, 2025) • Outs | 2026-03-02 |
| Results announced · Q1 2026 GERON CORPORATION – 2025 FINANCIAL RESULTS SUMMARY HEADLINE NUMBERS • RYTELO net product revenue: $48.0 million in Q4 2025; $183.6 million for full | 2026-02-25 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Geron Corporation — free to start.
Google PlayApp StoreData updated 2026-09-18.